Khaled Alsayegh at the King Abdullah International Medical Research Center is creating a Saudi Stem Cell Donor Registry, with 80,000 potential donors identified. The aim is to identify universal donors, reprogram their cells into induced pluripotent stem (iPS) cells, and create a gene bank for matched tissue transplants. Alsayegh is collaborating with Jesper Tegnér at KAUST to create pacemaker cells using single-cell RNA sequencing. Why it matters: This initiative could revolutionize precision medicine in KSA by providing readily available, matched cells for transplants, reducing the need for patient-specific reprogramming and improving treatment outcomes.
MBZUAI and the Department of Health – Abu Dhabi (DoH) have signed an agreement to collaborate on AI research across genomics, precision medicine, robotics, and AI-powered diagnostics. Signed on October 13, 2025, the MoU aims to drive breakthroughs in disease prevention, early detection, and therapeutics. The partnership seeks to translate AI research into tangible improvements in patient care within Abu Dhabi and beyond. Why it matters: This partnership signifies a major push to establish Abu Dhabi as a leader in biomedical research and AI-driven healthcare innovation.
The National Multiple Sclerosis Society has awarded funding to four research projects aimed at advancing multiple sclerosis research within the UAE. This initiative marks the third cycle of their Research Grant Programme. The funding supports local scientists and institutions in conducting studies related to the neurological disorder. Why it matters: This commitment strengthens the UAE's capacity in medical research, fostering local scientific innovation and addressing critical health challenges in the region.
The National Academies of Sciences, Engineering, and Medicine (US) has partnered with the Kuwait Foundation for the Advancement of Sciences (KFAS) to host a series of workshops on precision medicine. These workshops aim to share best practices, foster international collaboration, and strengthen research capacity in Kuwait and the broader Gulf region. Discussions will cover scientific advances, ethical considerations, and policy implications related to precision medicine. Why it matters: This collaboration signifies a concerted effort to advance cutting-edge medical research and build local expertise, positioning Kuwait as a key player in future healthcare innovation within the region.
KAUST and the International Medical Center (IMC) have signed an MoU to collaborate on medical research related to wellness, quality of life, and population health management. The partnership aims to develop AI applications for diagnosis and treatment, along with research in precision medicine and advanced therapies. The collaboration aligns with Saudi Vision 2030's goals to build a sustainable, knowledge-driven healthcare future. Why it matters: This agreement signifies a push to integrate AI and precision medicine into practical medical solutions within the Saudi healthcare system.
KAUST researchers demonstrated a new flash memory device design using gallium oxide, which can withstand harsh environments. In collaboration with the University of Michigan, KAUST researchers explained a key molecular event for the activation of an enzyme associated with cancer. The Summer 2023 issue of KAUST Discovery is now available. Why it matters: These research achievements highlight KAUST's contributions to advanced materials science and biomedical research, with potential applications in space technology and cancer treatment.
MBZUAI researchers presented a new causal representation learning framework at ICLR for identifying latent causal variables in multimodal biological data. The framework addresses the challenge of uncovering underlying causal factors from lab tests, genetic information, and medical images. The new approach can identify latent causal variables and their influence on observed biological outcomes across modalities. Why it matters: The model's ability to analyze causal mechanisms between modalities can lead to more complete insights in biomedical research.
The Russian Immune Diversity Atlas project aims to profile immune cells from people of different ancestries at a multiomics level. The goal is to reconstruct a reference atlas of the healthy immune system and investigate its perturbations in Type II Diabetes (T2D). The project seeks to identify novel mechanisms and genetic/epigenetic markers for early T2D diagnostics, prognosis, and therapy as part of the international Human Cell Atlas. Why it matters: Addressing genetic diversity in biomedical research, particularly in the context of the Human Cell Atlas, is crucial for personalized medicine and ensuring that treatments are effective across diverse populations in the Middle East and globally.